0000899243-17-005263.txt : 20170224 0000899243-17-005263.hdr.sgml : 20170224 20170224183640 ACCESSION NUMBER: 0000899243-17-005263 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170224 FILED AS OF DATE: 20170224 DATE AS OF CHANGE: 20170224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aimmune Therapeutics, Inc. CENTRAL INDEX KEY: 0001631650 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452748244 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BOULEVARD STREET 2: SUITE 300 CITY: BRISBANE STATE: CA ZIP: 94005-1884 BUSINESS PHONE: (650) 614-5220 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD STREET 2: SUITE 300 CITY: BRISBANE STATE: CA ZIP: 94005-1884 FORMER COMPANY: FORMER CONFORMED NAME: Allergen Research Corp DATE OF NAME CHANGE: 20150123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barrowcliffe Susan E. CENTRAL INDEX KEY: 0001664251 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37519 FILM NUMBER: 17639021 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 300 CITY: BRISBANE STATE: CA ZIP: 94005-1884 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-02-24 0 0001631650 Aimmune Therapeutics, Inc. AIMT 0001664251 Barrowcliffe Susan E. AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300 BRISBANE CA 94005-1884 0 1 0 0 General Manager, Europe Stock Option (right to buy) 19.63 2017-02-24 4 A 0 90000 0.00 A 2027-02-24 Common Stock 90000 90000 D The shares subject to the option will vest and become exercisable as to one-forty-eighth (1/48th) of the total number of shares subject to the option in successive, equal monthly installments measured from February 24, 2017, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Warren L. DeSouza, as Attorney in Fact for Susan E. Barrowcliffe 2017-02-24